Cargando…

Comparison Between Two Definitions of Contrast-Associated Acute Kidney Injury in Patients With Congestive Heart Failure

BACKGROUND: Different definitions of contrast-associated acute kidney injury (CA-AKI) have different predictive effects on prognosis. However, few studies explored the relationship between these definitions and long-term prognosis in patients with congestive heart failure (CHF). Thus, we aimed to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bo, Zheng, Yiying, Li, Huanqiang, Chen, Shuling, Zhou, Ziyou, Lun, Zhubin, Ying, Ming, Zhang, Lingyu, Mai, Ziling, Liu, Liwei, Zhou, Ziqing, Lin, Mengfei, Yang, Yongquan, Chen, Jiyan, Liu, Yong, Liu, Jin, Chen, Shiqun, Tan, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094707/
https://www.ncbi.nlm.nih.gov/pubmed/35571185
http://dx.doi.org/10.3389/fcvm.2022.763656
Descripción
Sumario:BACKGROUND: Different definitions of contrast-associated acute kidney injury (CA-AKI) have different predictive effects on prognosis. However, few studies explored the relationship between these definitions and long-term prognosis in patients with congestive heart failure (CHF). Thus, we aimed to evaluate this association and compared the population attributable risks (PAR) of different CA-AKI definitions. METHODS: This study enrolled 2,207 consecutive patients with CHF undergoing coronary angiography (CAG) in Guangdong Provincial People's Hospital. Two different definitions of CA-AKI were used: CA-AKI(A) was defined as an increase ≥.5 mg/dl or > 25% in serum creatinine (SCr) from baseline within 72 h after CAG, and CA-AKI(B) was defined as an increase of ≥.3 mg/dl or > 50% in SCr from baseline within 48 h after CAG. Kaplan-Meier methods and Cox regression were applied to evaluate the association between CA-AKI with long-term mortality. Population attributable risk (PAR) of different definitions for long-term prognosis was also calculated. RESULTS: During the 3.8-year median follow-up (interquartile range 2.1-6), the overall long-term mortality was 24.9%, and the long-term mortality in patients with the definitions of CA-AKI(A) and CA-AKI(B) were 30.4% and 34.3%, respectively. We found that CA-AKI(A) (HR: 1.44, 95% CI 1.19-1.74) and CA-AKI(B) (HR: 1.48, 95% CI 1.21-1.80) were associated with long-term mortality. The PAR was higher for CA-AKI(A) (9.6% vs. 8%). CONCLUSIONS: Our findings suggested that CA-AKI was associated with long-term mortality in patients with CHF irrespective of its definitions. The CA-AKI(A) was a much better definition of CA-AKI in patients with CHF due to its higher PAR. For these patients, cardiologists should pay more attention to the presence of CA-AKI, especially CA-AKI(A).